Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surveillance and Treatment Of Primary Hepatocellular Carcinoma: An International Cohort Study of High-Risk Patients for HCC Using Liquid Biopsy

NCT05342350 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05342350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05342350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surveillance and Treatment Of Primary Hepatocellular Carcinoma: An International Cohort Study of High-Risk Patients for HCC Using Liquid Biopsy
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Terminated
Start date
April 15, 2022
Completion date
June 7, 2025
Enrollment
360 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

early stage liver cancer, hepatocellular carcinoma, liver cancer, liver cirrhosis